De México 664-979-2020     Toll Free 888-541-0202
 
 
De México
664-979-2020
Toll Free
888-541-0202

Clinical evaluation of the model AT-45 silicone accommodating intraocular lens: results of feasibility and the initial phase of a Food and Drug Administration clinical trial. 11/7/2001 Cumming JS, Slade SG, Chayet A; AT-45 Study Group.
Ophthalmology. 2001 Nov;108(11):2005-9; discussion 2010.

OBJECTIVE: To evaluate the clinical outcomes in cataract patients after implantation of an accommodating intraocular lens, designed to move forward and backward along the visual axis. DESIGN: Prospective, noncomparative case series. PARTICIPANTS: Sixty-two patients scheduled for small-incision, extracapsular cataract extraction by phacoemulsification. METHODS: Twenty-eight eyes of 14 patients in the feasibility phase of the study and 48 eyes of 48 patients in the next phase of study underwent cataract extraction and implantation of the AT-45 accommodating intraocular lens. Prospective follow-up was analyzed at 1 month after surgery and compared with baseline characteristics 1 month and 3 to 6 months after surgery.

MORE

Established in 1986 · 1st IntraLASIK worldwide in 1995 · 1st Light Adjustable Lens worldwide in 2002
De México
664-979-2020
Toll Free
888-541-0202